Swiss and British pharmaceutical giants Novartis and GlaxoSmithKline (GSK) have swapped assets and agreed on creating a joint venture that will focus on consumer healthcare. The news comes amid troubling times for GSK, as the company has recently been involved in bribing scandals.
The deal will see Novartis buying GSK’s oncology portfolio for $16 billion (£9.5 billion), while the British firm would acquire Novartis’ vaccine business for $5.25 billion (£3.1 billion).
The two will also work together to create a consumer healthcare business, with GSK having greater control with an equity interest of 63.5%.
Novartis has also sold its animal health division to Eli Lilly and Company.
Joseph Jimenez, CEO of Novartis said the deal would strengthen the company financially.
“We believe the divestment of our smaller vaccines and animal health divisions will enable us to realise immediate value from these businesses for our shareholders, and those divisions will benefit from being part of large, global businesses that are also leaders in their segments”, he said.
“Patients will benefit from even higher levels of innovation that this focus may afford. Looking ahead, this positions Novartis well for future healthcare industry dynamics.”
CEO of GSK Sir Andrew Witty added that the deal would boost the company’s strategy to “generate sustainable, broadly sourced sales growth and improve long-term earnings”.
GSK has been involved in bribery scandals in China and Poland, along with other alleged cases in Iraq, Jordan and Lebanon. According to investigators, the company’s sales representatives were paying doctors to make them promote GSK’s drugs to patients.
However, ethical investors have said that they remain on the firm’s side, as long as it is committed to cleaning up its operations.
Photo Cathy Kaplan via Free Images
GlaxoSmithKline accused of bribing doctors to boost sales
Responsible investors react to GlaxoSmithKline bribery allegations
We’ll invest in GlaxoSmithKline for as long as it’s 100% committed to cleaning up its act
The Church in Wales under scrutiny over Big Pharma investment
Pharma firms call on government to invest in drug innovation
Like our Facebook Page
How Cities In Canada Are Addressing Climate Change
10 Tax Incentives for Businesses That are Lowering their Carbon Footprint
How to Manage Anxieties About Climate Change
Green Brands Must Understand Their Customers to Market Wisely
Key Necessities for Starting an Eco-Friendly Freelance Business
6 Ways To Overcome Cash Flow Challenges as a Green Business
Going Cashless Lowers Our Carbon Footprint and Has Other Pros and Cons
How to Be as Eco-Friendly as Possible on a Trip to New York
Why Brazed Plate Heat Exchangers Are Eco-Friendly
6 Steps For Making Crypto & Blockchain Eco-Friendly
Building a Career in Green Construction: Tips and Insights
Top 5 Benefits of Workplace Sustainability
The Role of Smart Technology in Managing EV Charging Stations
4 USA Vacation Destinations for an Eco-Friendly Trip
6 Wastewater Management Tips to Reduce Water Pollution
Why Internet Faxing Is A Sustainable Business Move
5 Ways Eco-Friendly Employers Can Boost Efficiency
What to Look for When Choosing an Eco-Friendly Locksmith
Flexible Return Policies Can Make Retail More Sustainable
Using Green Patents to Drive Sustainability & Eco-Friendly Designs
- Environment3 months ago
6 Home Improvements You Can Make to Help the Environment
- Environment10 months ago
4 Countries That Have Banned Single-Use Plastic
- Features9 months ago
5 Huge Support Tips for Eco-friendly eCommerce Brands
- Environment7 months ago
How to Ensure Your Home’s Eco-Friendly During Construction?